Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Feasibility Study of Ropeginterferon for Treatment Free Remission in CML Patients Who Have a Sustained Deep Molecular Response

NCT07105319 is registered in ClinicalTrials.gov with Dong-Wook Kim as lead sponsor.

NCT NCT07105319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07105319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Feasibility Study of Ropeginterferon for Treatment Free Remission in CML Patients Who Have a Sustained Deep Molecular Response
Lead sponsor
Dong-Wook Kim
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2021
Completion date
July 30, 2025
Enrollment
65 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cml (chronic myelogenous leukemia)